Exton, Mass.
Morphotek, the first biotech company to graduate from the Port of Technology incubator in West Philadelphia, will occupy a 41,000-sf facility in Exton. Previously located in 2,000 sf in the University City Science Center's Port of Technology building, the genomics-based life sciences company's agricultural technologies require land on which to grow crops. At present, 20,000-sf of the new Chester County headquarters are ready, and Morphotek plans to outfit the remainder for small-scale manufacturing over the next year. Expansion at the new site, including an option to add on to the back of the building, could easily bring the facility up to 70,000 sf. Morphotek is developing treatment and diagnosis antibodies for cancer and other diseases.